NSE: GLENMARK · 29 September 2026 · Dated market coverage
- The stock is +4.98% at ₹2,441.50.
- Likely reason:Strong volume-backed buying and sector outperformance
- Approximate traded value is₹307.19 crore.
- It is -3.79% from its 52-week high and +36.20% from its 52-week low.
- The stock is being compared withNifty Pharmaalongside the Nifty 50.
Why Is Glenmark Pharmaceuticals Share Price Rising Today?
Latest NSE EOD report: 2026-09-29. Today’s Volume: 1,258,203; 5-Day Avg. Volume: 817,296; 20-Day Avg. Volume: 488,980; Volume vs 20-Day Avg.: 2.57x; Delivery Quantity: 839,781; Delivery %: 65.75%; Number of Trades: 56,808.
Glenmark Pharmaceuticals shares surged 4.98% to close at ₹2,441.50 today, trading aggressively near the upper end of its intraday range between ₹2,292.10 and ₹2,441.50. Market participation was exceptionally strong, with trading volume clocking over 2.5 times its 20-day average and delivery quantity scaling up to 65.75%, signalling heavy institutional or delivery-based accumulation.
The stock notably outperformed the broader market and its sectoral peers. While the benchmark Nifty dipped 0.28%, the Nifty Pharma sector index posted a modest 0.64% gain, making Glenmark’s sharp upward trajectory one of the standout movers in the pharmaceutical space.
While no single headline-grabbing catalyst dropped today, the stock’s robust momentum coincides with a series of positive regulatory and operational updates over the past weeks, including the U.S. FDA’s VAI classification and Establishment Inspection Report (EIR) for its Goa facility, alongside the global expansion of its respiratory footprint with the Ryaltris launch in Brazil.
medium confidence
- Daily return of +4.98% with heavy volumes at 2.57x the 20-day average
- High delivery percentage of 65.75% indicating strong institutional interest
- Outperformance against Nifty (-0.28%) and Nifty Pharma (+0.64%)
Research & Brokerage Views
Brokerage views are third-party opinions and are not WittyTrades recommendations.
WittyTrades Data Insight
Price Position:The stock is near the upper end of the day’s trading range.
Move From Open:+4.24%.
Intraday Range:6.42% of the previous close.
5-Day Performance:-0.81%; 20-Day Performance:-1.17%.
Latest Company Developments
What Should Traders and Investors Watch Next?
- Execution of newly launched products in the US and Latin American markets
- Regulatory updates regarding other manufacturing plants and pending approvals
- Price action relative to the 52-week high of ₹2,537.60
Catalyst note:There is no single same-day trigger announced today, but the sharp rally is backed by heavy volume accumulation and sustained positive operational catalysts.
Frequently Asked Questions
What is the likely reason for today’s move?
Glenmark rallied sharply by nearly 5% accompanied by massive volume expansion (2.5x of 20-day average) and high delivery percentage, outpacing the broader pharmaceutical index. The move appears supported by recent positive regulatory developments like the U.S. FDA clearance for the Goa plant and institutional accumulation.
Is trading volume elevated?
Today’s volume is 1,258,203. The latest 20-day average available is 488,980, equivalent to about 2.57x of the recent average.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.
Article by:WittyTrades Research Desk